Your browser doesn't support javascript.
loading
Prevalencia del cáncer de próstata en la comuna de Talca, VII región Chile / Prevalence of prostate cancer in the seventh region of Chile
Baechler Rojas, Roberto; Henríquez Díaz, René; Aqueveque S., Ximena; Martínez P., María Elisa; Soto P., Alex.
Afiliación
  • Baechler Rojas, Roberto; Servicio de Salud del Maule. Hospital Regional de Talca. Departamento de Programas de las Personas.
  • Henríquez Díaz, René; Servicio de Salud del Maule. Hospital Regional de Talca. Departamento de Programas de las Personas.
  • Aqueveque S., Ximena; Servicio de Salud del Maule. Hospital Regional de Talca. Departamento de Programas de las Personas.
  • Martínez P., María Elisa; Servicio de Salud del Maule. Hospital Regional de Talca. Departamento de Programas de las Personas.
  • Soto P., Alex; Servicio de Salud del Maule. Hospital Regional de Talca. Departamento de Programas de las Personas.
Rev. méd. Chile ; 129(11): 1305-1310, nov. 2001. tab
Article en Es | LILACS | ID: lil-302637
Biblioteca responsable: CL1.1
ABSTRACT

Background:

In 1998, there were 1,218 deaths in Chile caused by prostate cancer. This figure results in a death rate of 16.6 per 100,000 males for this disease.

Aim:

To assess the prevalence of prostate cancer in the Seventh Region of Chile. Material and

methods:

A probabilistic sample of 327 males aged 40 to 59 years old was studied. In all, a codified questionnaire was applied, a digital rectal examination was performed and a blood sample was drawn to measure prostate specific antigen. All digital rectal examinations were performed by the same observer. Patients with an abnormal rectal examination or prostate specific antigen were subjected to a prostatic biopsy under ultrasound guidance.

Results:

In 14 subjects, the digital rectal examination was considered abnormal and in seven, prostate specific antigen was over 4 ng/ml. All subjects with elevated prostate specific antigen had an abnormal rectal examination. In three of the 14 subjects, the biopsy showed a well differentiated adenocarcinoma. All three were aged over 50 years old. The resulting calculated prevalence of prostate cancer was 9.2 per 1,000 males (CI 4.2-14.1).

Conclusions:

the cost effectiveness of screening for early diagnosis of prostate cancer must be calculated, to decide its incorporation in preventive medical examinations
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans / Male País/Región como asunto: America do sul / Chile Idioma: Es Revista: Rev. méd. Chile Asunto de la revista: MEDICINA Año: 2001 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Chile
Texto completo
Añadir a Mi BVS
Imprimir
XML
Buscar en Google
Texto completo: 1 Colección: 01-internacional Base de datos: LILACS Asunto principal: Neoplasias de la Próstata Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Adult / Humans / Male País/Región como asunto: America do sul / Chile Idioma: Es Revista: Rev. méd. Chile Asunto de la revista: MEDICINA Año: 2001 Tipo del documento: Article País de afiliación: Chile Pais de publicación: Chile